Format

Send to

Choose Destination
Heart Fail Rev. 2017 Jan;22(1):99-107. doi: 10.1007/s10741-016-9582-3.

Recent advances of adapter proteins in the regulation of heart diseases.

Author information

1
Cardiovascular Center, 305 Hospital of People's Liberation Army, Beijing, 100017, China.
2
Key Laboratory of Molecular Epigenetics of the Ministry of Education (MOE), School of Life Sciences, Northeast Normal University, Changchun, 130024, Jilin, China.
3
Cardiovascular Center, 305 Hospital of People's Liberation Army, Beijing, 100017, China. cysong8912@msn.com.
4
Key Laboratory of Molecular Epigenetics of the Ministry of Education (MOE), School of Life Sciences, Northeast Normal University, Changchun, 130024, Jilin, China. chenz100@nenu.edu.cn.

Abstract

Heart diseases are major causes of mortality. Cardiac hypertrophy, myocardial infarction (MI), viral cardiomyopathy, ischemic and reperfusion (I/R) heart injury finally lead to heart failure and death. Insulin and IGF1 signal pathways play key roles in normal cardiomyocyte growth and physiological cardiac hypertrophy while inflammatory signal pathway is associated with pathological cardiac hypertrophy, MI, viral cardiomyopathy, I/R heart injury, and heart failure. Adapter proteins are the major family proteins, which transduce signals from insulin, IGF1, or cytokine receptors to the downstream pathways and have been shown to regulate variety of heart diseases. Here, we summarized the recent advances in understanding the physiological and pathological roles of adapter proteins in heart failure.

KEYWORDS:

Adapter protein; Heart diseases; Inflammation; Insulin signaling

PMID:
27623843
DOI:
10.1007/s10741-016-9582-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center